Avance Phytotherapies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.13 M
as on 16-11-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -6.14%
(FY 2023)
- Profit -219.73%
(FY 2023)
- Ebitda -0.05%
(FY 2023)
- Net Worth -51.56%
(FY 2023)
- Total Assets -2.22%
(FY 2023)
About Avance Phytotherapies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Shivprakash Chinnappa, Pundarikakshudu Kilambi, and Harsh Rathnam serve as directors at the Company.
- CIN/LLPIN
U73100GJ2004PTC044109
- Company No.
044109
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Avance Phytotherapies Private Limited offer?
Avance Phytotherapies Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Popular Category, Liver Care, Stomach Care, Bone & Joint Care, Mind Care, Sexual Wellness.
Who are the key members and board of directors at Avance Phytotherapies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivprakash Chinnappa  | Managing Director | 10-May-2004 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pundarikakshudu Kilambi | Director | 10-May-2004 | Current |
| Harsh Rathnam | Director | 11-Dec-2019 | Current |
Financial Performance of Avance Phytotherapies.
Avance Phytotherapies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.14% decrease. The company also saw a substantial fall in profitability, with a 219.73% decrease in profit. The company's net worth observed a substantial decline by a decrease of 51.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avance Phytotherapies?
In 2023, Avance Phytotherapies had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Intervein Laboratories Private LimitedActive 19 years 4 monthsShivprakash Chinnappa is a mutual person
Novelgenix Therapeutics Private LimitedActive 13 years 7 monthsShivprakash Chinnappa and Harsh Rathnam are mutual person
Synchron Research Services Private LimitedActive 26 years 7 monthsShivprakash Chinnappa is a mutual person
Apiqule Pharmachem LlpActive 3 years 1 monthShivprakash Chinnappa and Harsh Rathnam are mutual person
- Remedios De Hierbas Herbalive Ayurvedic Healthcare LlpActive 5 years 11 months
Pundarikakshudu Kilambi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avance Phytotherapies?
Unlock and access historical data on people associated with Avance Phytotherapies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avance Phytotherapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avance Phytotherapies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
